Target Pharmacy vs Eli Lilly

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (79 vs 81)
Target Pharmacy logo

Target Pharmacy

LeaderHealthcare

Pharmacy Retail

CVS Health-operated pharmacy inside Target (NYSE: TGT) stores serving 100M weekly shoppers; $1.9B 2015 Target-to-CVS pharmacy acquisition creating store-within-store pharmacy integrated with Target Circle loyalty.

AI VisibilityBeta
Overall Score
B79
Category Rank
#21 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
75
Gemini
74

About

Target Pharmacy refers to the pharmacy services within Target Corporation's (NYSE: TGT) retail stores — providing prescription dispensing, immunizations, and health consultations to Target shoppers combining pharmacy errands with retail shopping. In 2015, Target sold its pharmacy and clinic operations to CVS Health (NYSE: CVS) for $1.9 billion, converting the in-store locations to CVS Pharmacy branding under a long-term licensing agreement — making what shoppers call "Target Pharmacy" operationally a CVS pharmacy located inside Target's 1,900+ US stores, operating under CVS management while Target shoppers earn Target Circle rewards on eligible pharmacy purchases.

Full profile
Eli Lilly logo

Eli Lilly

LeaderHealthcare

General

Indianapolis global pharma (NYSE: LLY) at $45B 2024 revenue (+32%); first healthcare company to $1T market cap (Nov 2024) with Mounjaro/Zepbound tirzepatide (37% revenue) and oral GLP-1 orforglipron Phase 3 competing with Novo Nordisk.

AI VisibilityBeta
Overall Score
A81
Category Rank
#17 of 596
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
80
Perplexity
75
Gemini
77

About

Eli Lilly and Company is an Indianapolis, Indiana-based global pharmaceutical company — publicly traded on the New York Stock Exchange (NYSE: LLY) as an S&P 500 Dow Jones Industrial Average component — that in November 2024 became the world's most valuable pharmaceutical company with a historic $1 trillion market capitalization, the first healthcare company ever to reach this milestone. In fiscal year 2024, Lilly achieved approximately $45 billion in revenue, representing 32% growth from 2023, driven by blockbuster GLP-1 medications tirzepatide (Mounjaro for type 2 diabetes and Zepbound for obesity and obstructive sleep apnea), which together accounted for 37% of 2024 revenues. Other key products include Trulicity (dulaglutide, 12% of revenue), Humalog (insulin lispro, 5%), and Kisunla (donanemab), the first new Alzheimer's therapy approved for early symptomatic disease in 2024. An oral GLP-1 pill (orforglipron) is in Phase 3 clinical trials. CEO David Ricks has led the company since 2017. Founded in 1876 by Colonel Eli Lilly in Indianapolis, the company pioneered mass production of Jonas Salk's polio vaccine in 1955 and was among the first to produce human insulin using recombinant DNA technology.

Full profile

AI Visibility Head-to-Head

79
Overall Score
81
#21
Category Rank
#17
83
AI Consensus
71
stable
Trend
stable
79
ChatGPT
80
75
Perplexity
75
74
Gemini
77
79
Claude
86
80
Grok
85

Key Details

Category
Pharmacy Retail
General
Tier
Leader
Leader
Entity Type
company
company

Capabilities & Ecosystem

Capabilities

Only Target Pharmacy
Pharmacy Retail

Integrations

Target Pharmacy is classified as company (part of CVS Health). Eli Lilly is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.